whole human genome mirna microarray v. 3 (Agilent technologies)
Agilent technologies is a verified supplier 
Agilent technologies manufactures this product 
90
Structured Review
Agilent technologies
whole human genome mirna microarray v. 3
![Proposed candidate miRNAs in various body fluids of PD compared to healthy controls]()
Whole Human Genome Mirna Microarray V. 3, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole+human+genome+mirna+microarray+v%2E3/pmc07001448-14-37-44
Average 90 stars, based on 1 article reviews
Whole Human Genome Mirna Microarray V. 3, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole+human+genome+mirna+microarray+v%2E3/pmc07001448-14-37-44
Average 90 stars, based on 1 article reviews
whole human genome mirna microarray v. 3 - by Bioz Stars,
2026-10
90/100 stars
Images
1) Product Images from "Clinical Application of Circulating MicroRNAs in Parkinson's Disease: The Challenges and Opportunities as Diagnostic Biomarker"
Article Title: Clinical Application of Circulating MicroRNAs in Parkinson's Disease: The Challenges and Opportunities as Diagnostic Biomarker
Journal: Annals of Indian Academy of Neurology
doi: 10.4103/aian.AIAN_440_19
Figure Legend Snippet: Proposed candidate miRNAs in various body fluids of PD compared to healthy controls
Techniques Used: Isolation, Derivative Assay, TLDA Assay, Spectrophotometry, Electrophoresis, Hybridization, Real-time Polymerase Chain Reaction, Microarray, Quantitative RT-PCR, Fluorescence, Protein Extraction, Reverse Transcription Polymerase Chain Reaction, Sequencing, Next-Generation Sequencing
Related Articles
Microarray:Article Title: Role of MicroRNAs in Parkinson’s Disease Article Snippet: , hsa-miR-200a , ↑ , - , - , Plasma from 32 PD patients vs. 32 controls , RNA Sequencing Assay:Article Title: Role of MicroRNAs in Parkinson’s Disease Article Snippet: , hsa-miR-200a , ↑ , - , - , Plasma from 32 PD patients vs. 32 controls , Isolation:Article Title: Role of MicroRNAs in Parkinson’s Disease Article Snippet: , hsa-miR-200a , ↑ , - , - , Plasma from 32 PD patients vs. 32 controls , TLDA Assay:Article Title: Role of MicroRNAs in Parkinson’s Disease Article Snippet: , hsa-miR-200a , ↑ , - , - , Plasma from 32 PD patients vs. 32 controls , Real-time Polymerase Chain Reaction:Article Title: Role of MicroRNAs in Parkinson’s Disease Article Snippet: , hsa-miR-200a , ↑ , - , - , Plasma from 32 PD patients vs. 32 controls , Transgenic Assay:Article Title: Role of MicroRNAs in Parkinson’s Disease Article Snippet: , hsa-miR-200a , ↑ , - , - , Plasma from 32 PD patients vs. 32 controls , Expressing:Article Title: Role of MicroRNAs in Parkinson’s Disease Article Snippet: , hsa-miR-200a , ↑ , - , - , Plasma from 32 PD patients vs. 32 controls , Next-Generation Sequencing:Article Title: Role of MicroRNAs in Parkinson’s Disease Article Snippet: , hsa-miR-200a , ↑ , - , - , Plasma from 32 PD patients vs. 32 controls , |